A detailed history of Five Oceans Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Five Oceans Advisors holds 2,103 shares of ABT stock, worth $236,881. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,103
Holding current value
$236,881
% of portfolio
0.13%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$100.73 - $112.44 $211,835 - $236,461
2,103 New
2,103 $218,000
Q4 2022

Jan 17, 2023

BUY
$95.06 - $111.52 $190 - $223
2 Added 0.07%
2,938 $0
Q3 2022

Nov 02, 2022

SELL
$96.76 - $112.03 $3,580 - $4,145
-37 Reduced 1.24%
2,936 $284,000
Q2 2022

Jul 15, 2022

SELL
$102.07 - $123.37 $5,613 - $6,785
-55 Reduced 1.82%
2,973 $323,000
Q1 2022

Apr 19, 2022

BUY
$114.02 - $139.04 $2,166 - $2,641
19 Added 0.63%
3,028 $358,000
Q4 2021

Jan 14, 2022

BUY
$115.53 - $141.46 $14,094 - $17,258
122 Added 4.23%
3,009 $423,000
Q3 2021

Oct 13, 2021

BUY
$116.66 - $129.06 $336,797 - $372,596
2,887 New
2,887 $341,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Five Oceans Advisors Portfolio

Follow Five Oceans Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Five Oceans Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Five Oceans Advisors with notifications on news.